Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Diabetes Complications. 2015 Dec 9;30(3):524–532. doi: 10.1016/j.jdiacomp.2015.12.005

Table 3.

Performance metrics with the primary care prevalence. LCL and UCL represent the lower and upper 95% confidence limits, respectively.

RETeval cutoff value Sensitivity Specificity Predictive Power of Test Percent of Tested Sample
Positive Test Negative Test
Positive Negative True False True False
17.6 93% 52% 8% 99.5% 4.1% 46% 50% 0.2%
LCL 73% 47% 5% 97% 2.4% 41% 45% 0.0%
UCL 99.9% 57% 13% 100.0% 6.5% 51% 55% 1.3%
18.1 90% 57% 9% 99.2% 3.8% 41% 55% 0.5%
LCL 65% 52% 5.0% 97% 2.2% 36% 50% 0.1%
UCL 99% 62% 14% 99.9% 6.2% 46% 59% 1.7%
19.1 88% 67% 11% 99.1% 3.8% 31% 64% 0.5%
LCL 65% 62% 6% 97% 2.2% 27% 59% 0.1%
UCL 99% 72% 17% 99.9% 6.2% 36% 69% 1.7%
20.0 83% 78% 15% 99% 3.6% 21% 75% 0.7%
LCL 59% 74% 9% 97% 2.0% 17% 71% 0.1%
UCL 96% 82% 23% 99.9% 5.9% 25% 79% 2.1%
21.2 73% 84% 17% 99% 3.1% 15% 80% 1.2%
LCL 47% 80% 9% 97% 1.7% 12% 76% 0.4%
UCL 90% 87% 27% 99.5% 5.3% 19% 84% 2.8%